Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 336

    1.

    Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.

    Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, Frisch M.

    Arthritis Res Ther. 2006;8(4):R133.

    PMID:
    16872514
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.

    Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M.

    Arthritis Rheum. 2007 May;56(5):1446-53.

    PMID:
    17469102
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

    Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR.

    Arthritis Res Ther. 2004;6(4):R303-8. Epub 2004 May 11.

    PMID:
    15225365
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.

    Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.

    Arthritis Rheum. 2005 Oct;52(10):3058-62.

    PMID:
    16200610
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.

    van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.

    Arthritis Rheum. 2007 Feb;56(2):425-32.

    PMID:
    17265477
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.

    Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, Montgomery DS, Binks MH, Wilson AG.

    Arthritis Res Ther. 2006;8(4):R128.

    PMID:
    16859535
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.

    López-Longo FJ, Oliver-Miñarro D, de la Torre I, González-Díaz de Rábago E, Sánchez-Ramón S, Rodríguez-Mahou M, Paravisini A, Monteagudo I, González CM, García-Castro M, Casas MD, Carreño L.

    Arthritis Rheum. 2009 Apr 15;61(4):419-24.

    PMID:
    19333979
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

    Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.

    Arthritis Rheum. 2005 Nov;52(11):3433-8.

    PMID:
    16255021
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.

    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR.

    Arthritis Rheum. 2006 Apr;54(4):1117-21.

    PMID:
    16572446
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].

    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.

    Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.

    PMID:
    19149089
    [PubMed - indexed for MEDLINE]
    12.

    Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.

    Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, Wolfe F, Lum RF, Massarotti E, Weisman M, Bombardier C, Karlson EW, Criswell LA, Vlietinck R, Gregersen PK.

    Arthritis Rheum. 2007 Jun;56(6):1745-53.

    PMID:
    17530703
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

    Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, Breedveld FC, Toes RE, Huizinga TW.

    Ann Rheum Dis. 2006 Mar;65(3):366-71. Epub 2005 Jul 13.

    PMID:
    16014670
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?

    Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP.

    J Clin Rheumatol. 2006 Aug;12(4):172-5.

    PMID:
    16891919
    [PubMed - indexed for MEDLINE]
    15.

    The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.

    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.

    Scand J Rheumatol. 2008 May-Jun;37(3):183-7.

    PMID:
    18465452
    [PubMed - indexed for MEDLINE]
    16.

    Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.

    Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieudé P, Prum B, Cornélis F, Petit-Teixeira E.

    Ann Rheum Dis. 2008 Apr;67(4):466-70. Epub 2007 Jul 27.

    PMID:
    17660221
    [PubMed - indexed for MEDLINE]
    17.

    [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].

    Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM.

    Biomedica. 2004 Jun;24(2):140-52. Review. Spanish.

    PMID:
    15495594
    [PubMed - indexed for MEDLINE]
    19.

    Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.

    Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, Breedveld FC, de Vries RR, Huizinga TW, Toes RE.

    Arthritis Rheum. 2007 Sep;56(9):2913-8.

    PMID:
    17763436
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

    van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW.

    Arthritis Rheum. 2004 Mar;50(3):709-15.

    PMID:
    15022309
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk